The FDA approved a new ketamine (KETARx, PharmaTher) for the treatment of surgical pain management. The FDA previously issued a pair of complete response letters for the application in 2024, citing ...

There remains a need for organizations and stakeholders to develop guidance for prescribing ketamine as a pain treatment.

An overview of the topics to be most important published in the past year, at the 2025 annual meeting of the Society for Ambulatory Anesthesia.

Clinical research has created evidence-based guidelines and approaches to pediatric airway management that will improve outcomes.